These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

774 related items for PubMed ID: 17724224

  • 21. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
    Cashman SM, Bowman L, Christofferson J, Kumar-Singh R.
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
    [Abstract] [Full Text] [Related]

  • 22. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization.
    Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Umezawa K, Ohno S, Oike Y, Ishida S.
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2555-62. PubMed ID: 17932319
    [Abstract] [Full Text] [Related]

  • 23. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
    Mizutani T, Ashikari M, Tokoro M, Nozaki M, Ogura Y.
    Invest Ophthalmol Vis Sci; 2013 Feb 28; 54(2):1564-72. PubMed ID: 23404125
    [Abstract] [Full Text] [Related]

  • 24. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization.
    Izumi-Nagai K, Nagai N, Ozawa Y, Mihara M, Ohsugi Y, Kurihara T, Koto T, Satofuka S, Inoue M, Tsubota K, Okano H, Oike Y, Ishida S.
    Am J Pathol; 2007 Jun 28; 170(6):2149-58. PubMed ID: 17525280
    [Abstract] [Full Text] [Related]

  • 25. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.
    Tomida D, Nishiguchi KM, Kataoka K, Yasuma TR, Iwata E, Uetani R, Kachi S, Terasaki H.
    Invest Ophthalmol Vis Sci; 2011 May 16; 52(6):3193-9. PubMed ID: 21296829
    [Abstract] [Full Text] [Related]

  • 26. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
    Mochimaru H, Nagai N, Hasegawa G, Kudo-Saito C, Yaguchi T, Usui Y, Kurihara T, Koto T, Satofuka S, Shinoda H, Ozawa Y, Tsubota K, Kawakami Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Oct 16; 48(10):4795-801. PubMed ID: 17898306
    [Abstract] [Full Text] [Related]

  • 27. [Expression of vascular endothelial growth factor and its receptor in experimental choroidal neovascularization in rat].
    Zhao SH, He SZ, Shi XH.
    Zhonghua Yan Ke Za Zhi; 2004 Aug 16; 40(8):522-7. PubMed ID: 15454039
    [Abstract] [Full Text] [Related]

  • 28. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization.
    Yoshikawa N, Noda K, Ozawa Y, Tsubota K, Mashima Y, Ishida S.
    Mol Vis; 2012 Aug 16; 18():593-600. PubMed ID: 22419852
    [Abstract] [Full Text] [Related]

  • 29. Focal adhesion kinase signaling pathway participates in the formation of choroidal neovascularization and regulates the proliferation and migration of choroidal microvascular endothelial cells by acting through HIF-1 and VEGF expression in RPE cells.
    Zhu J, Wang YS, Zhang J, Zhao W, Yang XM, Li X, Jiang TS, Yao LB.
    Exp Eye Res; 2009 May 16; 88(5):910-8. PubMed ID: 19111720
    [Abstract] [Full Text] [Related]

  • 30. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
    Murata T, He S, Hangai M, Ishibashi T, Xi XP, Kim S, Hsueh WA, Ryan SJ, Law RE, Hinton DR.
    Invest Ophthalmol Vis Sci; 2000 Jul 16; 41(8):2309-17. PubMed ID: 10892878
    [Abstract] [Full Text] [Related]

  • 31. Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium.
    Fujimoto T, Sonoda KH, Hijioka K, Sato K, Takeda A, Hasegawa E, Oshima Y, Ishibashi T.
    Invest Ophthalmol Vis Sci; 2010 Sep 16; 51(9):4694-702. PubMed ID: 20393111
    [Abstract] [Full Text] [Related]

  • 32. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F, Das B.
    Am J Ophthalmol; 2007 Nov 16; 144(5):761-8. PubMed ID: 17869204
    [Abstract] [Full Text] [Related]

  • 33. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy.
    Moore JE, McMullen TC, Campbell IL, Rohan R, Kaji Y, Afshari NA, Usui T, Archer DB, Adamis AP.
    Invest Ophthalmol Vis Sci; 2002 Sep 16; 43(9):2905-15. PubMed ID: 12202509
    [Abstract] [Full Text] [Related]

  • 34. Excessive retinol intake exacerbates choroidal neovascularization through upregulated vascular endothelial growth factor in retinal pigment epithelium in mice.
    Tan X, Takahashi H, Nishida J, Aoki A, Inoue T, Yanagi Y.
    Exp Eye Res; 2015 Feb 16; 131():77-83. PubMed ID: 25576666
    [Abstract] [Full Text] [Related]

  • 35. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.
    Hu W, Criswell MH, Fong SL, Temm CJ, Rajashekhar G, Cornell TL, Clauss MA.
    Exp Eye Res; 2009 Jan 16; 88(1):79-91. PubMed ID: 19013152
    [Abstract] [Full Text] [Related]

  • 36. Preventing stem cell incorporation into choroidal neovascularization by targeting homing and attachment factors.
    Sengupta N, Caballero S, Mames RN, Timmers AM, Saban D, Grant MB.
    Invest Ophthalmol Vis Sci; 2005 Jan 16; 46(1):343-8. PubMed ID: 15623794
    [Abstract] [Full Text] [Related]

  • 37. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
    Ogata N, Wada M, Otsuji T, Jo N, Tombran-Tink J, Matsumura M.
    Invest Ophthalmol Vis Sci; 2002 Apr 16; 43(4):1168-75. PubMed ID: 11923262
    [Abstract] [Full Text] [Related]

  • 38. Octreotide inhibits choroidal neovascularization in rats.
    Qu Y, Zhang S, Xu X, Wang H, Li J, Zhou F, Wei F.
    Ophthalmic Res; 2009 Apr 16; 42(1):36-42. PubMed ID: 19478539
    [Abstract] [Full Text] [Related]

  • 39. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
    Wakusawa R, Abe T, Sato H, Yoshida M, Kunikata H, Sato Y, Nishida K.
    Am J Ophthalmol; 2008 Aug 16; 146(2):235-243. PubMed ID: 18486097
    [Abstract] [Full Text] [Related]

  • 40. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
    Hoffmann S, Friedrichs U, Eichler W, Rosenthal A, Wiedemann P.
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec 16; 240(12):996-1002. PubMed ID: 12483322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.